Arjuna Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.38M | Sell |
34,443
-1,196
| -3% | -$82.5K | 0.63% | 41 |
|
|
2025
Q1 | $2.47M | Sell |
35,639
-1,878
| -5% | -$130K | 0.69% | 40 |
|
|
2024
Q4 | $3.23M | Sell |
37,517
-9,750
| -21% | -$839K | 0.86% | 36 |
|
|
2024
Q3 | $5.63M | Sell |
47,267
-6,116
| -11% | -$728K | 1.46% | 17 |
|
|
2024
Q2 | $7.62M | Sell |
53,383
-17
| -0% | -$2.43K | 2.05% | 11 |
|
|
2024
Q1 | $6.86M | Buy |
53,400
+10,696
| +25% | +$1.37M | 1.94% | 14 |
|
|
2023
Q4 | $4.42M | Buy |
42,704
+2,106
| +5% | +$218K | 1.38% | 23 |
|
|
2023
Q3 | $3.69M | Sell |
40,598
-716
| -2% | -$65.1K | 1.32% | 22 |
|
|
2023
Q2 | $3.34M | Buy |
41,314
+158
| +0.4% | +$12.8K | 1.18% | 25 |
|
|
2023
Q1 | $3.27M | Sell |
41,156
-6,412
| -13% | -$510K | 1.28% | 18 |
|
|
2022
Q4 | $3.22M | Sell |
47,568
-1,230
| -3% | -$83.2K | 1.48% | 20 |
|
|
2022
Q3 | $2.43M | Buy |
48,798
+1,652
| +4% | +$82.3K | 1.2% | 26 |
|
|
2022
Q2 | $2.63M | Buy |
47,146
+992
| +2% | +$55.3K | 1.27% | 26 |
|
|
2022
Q1 | $2.56M | Sell |
46,154
-2,268
| -5% | -$126K | 1.07% | 25 |
|
|
2021
Q4 | $2.71M | Buy |
48,422
+5,846
| +14% | +$327K | 0.99% | 30 |
|
|
2021
Q3 | $2.04M | Buy |
42,576
+4,928
| +13% | +$237K | 0.83% | 37 |
|
|
2021
Q2 | $1.58M | Buy |
37,648
+5,988
| +19% | +$251K | 0.68% | 48 |
|
|
2021
Q1 | $1.07M | Buy |
31,660
+25,232
| +393% | +$850K | 0.52% | 54 |
|
|
2020
Q4 | $224K | Buy |
6,428
+106
| +2% | +$3.69K | 0.12% | 87 |
|
|
2020
Q3 | $219K | Sell |
6,322
-294
| -4% | -$10.2K | 0.14% | 79 |
|
|
2020
Q2 | $217K | Buy |
+6,616
| New | +$217K | 0.15% | 83 |
|